Thank you for visiting Gilead.com. Please explore this section for the latest news about Gilead, our groundbreaking research and our therapeutics.

Please see Gilead-at-a-Glance to learn more about the company and our portfolio of products.

Sign-up to receive email alerts whenever new company information is posted to the site.

Recent News

September 1, 2010
Gilead Provides Update on $5 Billion Stock Repurchase Program

August 19, 2010
Gilead Sciences Announces Notification of ANDA Filing for Hepsera(R)

July 30, 2010
Gilead Closes Sale of $2.2 Billion of Convertible Senior Notes

July 27, 2010
Gilead Prices $2.2 Billion of Convertible Senior Notes; Company to Repurchase $1 Billion in Common Stock

July 26, 2010
Gilead to Offer $2.2 Billion of Convertible Senior Notes; Company to Repurchase $1 Billion in Common Stock

July 20, 2010
Gilead Sciences Announces Second Quarter 2010 Financial Results

July 14, 2010
Gilead Sciences Files Patent Infringement Lawsuit Against Lupin Limited

July 13, 2010
Gilead Sciences to Release Second Quarter 2010 Financial Results on Tuesday, July 20, 2010